Zero incidence of inhibitor development in previously treated haemophilia A, HIV-negative patients upon exposure to a plasma-derived high-purity and double viral inactivated factor VIII concentrate.

Source:http://linkedlifedata.com/resource/pubmed/id/9873861

Download in:

View as

General Info

PMID
9873861